113 related articles for article (PubMed ID: 11731043)
1. Doppler quantitative measures by region to discriminate prostate cancer.
Potdevin TC; Moskalik AP; Fowlkes JB; Bude RO; Carson PL
Ultrasound Med Biol; 2001 Oct; 27(10):1305-10. PubMed ID: 11731043
[TBL] [Abstract][Full Text] [Related]
2. Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer.
Moskalik AP; Rubin MA; Wojno KJ; Bree R; Rubin JM; Fowlkes JB; Montie JE; Manley S; Carson PL
J Ultrasound Med; 2001 Jul; 20(7):713-22. PubMed ID: 11444729
[TBL] [Abstract][Full Text] [Related]
3. Analysis of three-dimensional ultrasound Doppler for the detection of prostate cancer.
Moskalik A; Carson PL; Rubin JM; Bree RL; Fowlkes JB; Rubin MA; Wojno K; Manley S; Montie JE
Urology; 2001 Jun; 57(6):1128-32. PubMed ID: 11377325
[TBL] [Abstract][Full Text] [Related]
4. Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer.
Sauvain JL; Palascak P; Bourscheid D; Chabi C; Atassi A; Bremon JM; Palascak R
Eur Urol; 2003 Jul; 44(1):21-30; discussion 30-1. PubMed ID: 12814671
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection using power Doppler imaging.
Okihara K; Ukimura O; Mizutani Y; Kawauchi A; Nakao M; Miki T
Drugs Today (Barc); 2003 Jun; 39(6):389-98. PubMed ID: 12944993
[TBL] [Abstract][Full Text] [Related]
6. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings.
Cornud F; Hamida K; Flam T; Hélénon O; Chrétien Y; Thiounn N; Correas JM; Casanova JM; Moreau JF
AJR Am J Roentgenol; 2000 Oct; 175(4):1161-8. PubMed ID: 11000183
[TBL] [Abstract][Full Text] [Related]
7. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results.
Ives EP; Gomella LG; Halpern EJ
Radiology; 2005 Oct; 237(1):197-201. PubMed ID: 16183933
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional registration of prostate images from histology and ultrasound.
Taylor LS; Porter BC; Nadasdy G; di Sant'Agnese PA; Pasternack D; Wu Z; Baggs RB; Rubens DJ; Parker KJ
Ultrasound Med Biol; 2004 Feb; 30(2):161-8. PubMed ID: 14998668
[TBL] [Abstract][Full Text] [Related]
9. Transrectal doppler ultrasound during prostate biopsy: clinical utility and limitations.
Ezquer A; Ortega Hrescak MC; Sanagua C; Roggia-Rebullida P; López R; Cenice F; Veglia FH; Veglia F; Fernández A
Actas Urol Esp; 2015; 39(1):13-9. PubMed ID: 24630842
[TBL] [Abstract][Full Text] [Related]
10. Using gray-scale and color and power Doppler sonography to detect prostatic cancer.
Halpern EJ; Strup SE
AJR Am J Roentgenol; 2000 Mar; 174(3):623-7. PubMed ID: 10701599
[TBL] [Abstract][Full Text] [Related]
11. High-frequency Doppler US of the prostate: effect of patient position.
Halpern EJ; Frauscher F; Forsberg F; Strup SE; Nazarian LN; O'Kane P; Gomella LG
Radiology; 2002 Mar; 222(3):634-9. PubMed ID: 11867778
[TBL] [Abstract][Full Text] [Related]
12. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.
Sedelaar JP; Aarnink RG; van Leenders GJ; Beerlage HP; Debruyne FM; Wijkstra H; de La Rosette JJ
Eur Urol; 2000 May; 37(5):559-68. PubMed ID: 10765094
[TBL] [Abstract][Full Text] [Related]
13. Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer.
Strigari L; Marsella A; Canitano S; Gomellini S; Arcangeli S; Genovese E; Saracino B; Petrongari MG; Sentinelli S; Crecco M; Benassi M; Arcangeli G
Med Phys; 2008 Nov; 35(11):4793-9. PubMed ID: 19070211
[TBL] [Abstract][Full Text] [Related]
14. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival.
Ismail M; Petersen RO; Alexander AA; Newschaffer C; Gomella LG
Urology; 1997 Dec; 50(6):906-12. PubMed ID: 9426722
[TBL] [Abstract][Full Text] [Related]
15. Color and power Doppler sonography in the diagnosis of prostate cancer: comparison between vascular density and total vascularity.
Arger PH; Malkowicz SB; VanArsdalen KN; Sehgal CM; Holzer A; Schultz SM
J Ultrasound Med; 2004 May; 23(5):623-30. PubMed ID: 15154528
[TBL] [Abstract][Full Text] [Related]
16. Detection of prostate cancer with a microbubble ultrasound contrast agent.
Frauscher F; Klauser A; Halpern EJ; Horninger W; Bartsch G
Lancet; 2001 Jun; 357(9271):1849-50. PubMed ID: 11410195
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric 3D in vivo ultrasound vibroelastography imaging of prostate cancer: Preliminary results.
Moradi M; Mahdavi SS; Nir G; Mohareri O; Koupparis A; Gagnon LO; Fazli L; Casey RG; Ischia J; Jones EC; Goldenberg SL; Salcudean SE
Med Phys; 2014 Jul; 41(7):073505. PubMed ID: 24989419
[TBL] [Abstract][Full Text] [Related]
18. Correlation between prostate cancer grade and vascularity on color doppler imaging: preliminary findings.
Tang J; Li S; Li J; Luo Y; Xu J; Zhang Y; Li X; Shi H; Zhang G
J Clin Ultrasound; 2003 Feb; 31(2):61-8. PubMed ID: 12539246
[TBL] [Abstract][Full Text] [Related]
19. Re: Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection.
Peyromaure M
J Urol; 2002 Oct; 168(4 Pt 1):1505-6; author reply 1506. PubMed ID: 12352440
[No Abstract] [Full Text] [Related]
20. Prostatic cancer: role of color Doppler imaging in transrectal sonography.
Lavoipierre AM; Snow RM; Frydenberg M; Gunter D; Reisner G; Royce PL; Lavoipierre GJ
AJR Am J Roentgenol; 1998 Jul; 171(1):205-10. PubMed ID: 9648790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
